Posted inNews and Updates
Essential Guide: How to Join a Cancer Clinical Trial
Considering a cancer clinical trial? Learn how to navigate inclusion criteria, the consent process, and key questions to ask your oncologist before joining.
Posted inNews and Updates
QuantHealth Raises $45M to Advance AI Clinical Trials
QuantHealth secures $45M in Series B funding to scale its AI-driven clinical trial simulation platform, aimed at reducing drug development risks and costs.
Posted inNews and Updates
Can Oral Semaglutide Reduce Alcohol Intake? New Study Results
Could semaglutide treat alcohol addiction? New research shows promising reductions in heavy drinking days, suggesting a new path for AUD treatment.
Posted inNews and Updates
FDA Strategy to Modernize Clinical Trial Development
The FDA is revolutionizing clinical trials through decentralized methods and adaptive designs to accelerate drug development and patient access.
Posted inNews and Updates
Radiopharm Secures $16M Funding Following Trial Successes
Radiopharm Theranostics raises $16M following successful clinical trial milestones in radiopharmaceutical oncology research. Learn about their latest progress.
Posted inNews and Updates
FDA Advisory Panel Backs Expanded Use of Peptide Therapy
An FDA advisory panel has recommended expanded use for peptide-based therapies, signaling a major shift in treatment for chronic metabolic conditions.
Posted inNews and Updates
Boston Scientific Issues Urgent Recall for Catheter Devices
Boston Scientific has issued a Class I recall for specific catheters due to risks of separation. Learn the critical safety steps for clinical teams.
Posted inNews and Updates
New GLP-1 Study: Calocurb Aids Weight Loss Without Muscle Loss
New research reveals that Calocurb effectively triggers GLP-1 for fat loss while protecting lean muscle mass. Learn how this supplement aids metabolic health.
Posted inNews and Updates
FDA Approves New Targeted NSCLC Therapy for GSK
The FDA has approved a new targeted therapy for non-small cell lung cancer (NSCLC), marking a major expansion in precision oncology for GSK.
Posted inNews and Updates
New Alzheimer’s Drug Shows Promise in Targeting Brain Protein
A breakthrough Alzheimer’s drug targeting a complex protein has shown success in slowing cognitive decline, offering new hope for neurodegenerative care.